Brain Circuits in Schizophrenia and Smoking
NCT01425684 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 837
Last updated 2021-05-03
Summary
The principle aim of the project is to identify the key brain circuits associated with smoking and especially smoking in high risk population. The investigators hope that the study will provide concrete biomarkers for new therapeutic development and ultimately reducing the smoking related health burden.
Conditions
- Schizophrenia
- Schizoaffective Disorder
- Schizophreniform Disorder
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
University of Maryland, Baltimore
lead OTHER
Principal Investigators
-
L.Elliot Hong, M.D. · Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine
Eligibility
- Min Age
- 12 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-12-20
- Primary Completion
- 2021-04-30
- Completion
- 2021-04-30
Countries
- United States
Study Locations
More Related Trials
-
Cigarette Smoking in Smokers With and Without Schizophrenia
NCT04001114 ·Status: COMPLETED ·Phase: NA
-
Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia
NCT01034085 ·Status: COMPLETED
-
Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia
NCT00770237 ·Status: COMPLETED ·Phase: NA
-
Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence
NCT01037075 ·Status: COMPLETED
-
Nicotinic Modulation of the Default Network of Resting Brain Function
NCT01240616 ·Status: COMPLETED
-
Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia
NCT00407277 ·Status: COMPLETED ·Phase: NA
-
Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia
NCT01213524 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia
NCT00061789 ·Status: COMPLETED ·Phase: PHASE2
-
Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder
NCT00382915 ·Status: COMPLETED
-
Predictors of Treatment Outcome for Smokers With and Without Schizophrenia
NCT00501007 ·Status: COMPLETED
-
Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia
NCT01036568 ·Status: COMPLETED
-
Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States
NCT01425671 ·Status: COMPLETED
-
Tobacco Craving and Triggers in Persons With Schizophrenia
NCT01846065 ·Status: COMPLETED
-
Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia
NCT01399437 ·Status: COMPLETED
-
Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia
NCT02069392 ·Status: COMPLETED ·Phase: NA
-
Very Low Nicotine Cigarettes in Smokers With Schizophrenia
NCT02019459 ·Status: COMPLETED ·Phase: PHASE2
-
Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2
NCT00135772 ·Status: COMPLETED
-
Examining Persistence in Smokers With Schizophrenia
NCT03346291 ·Status: COMPLETED ·Phase: NA
-
Nicotinic Modulation of the Default Network
NCT01223404 ·Status: COMPLETED ·Phase: NA
-
Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects
NCT00690170 ·Status: COMPLETED ·Phase: PHASE1
-
Nicotine Effects on Endophenotypes of Schizophrenia
NCT01315002 ·Status: COMPLETED ·Phase: NA
-
Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic
NCT02128919 ·Status: COMPLETED ·Phase: NA
-
Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
NCT00136760 ·Status: COMPLETED ·Phase: PHASE2
-
Minocycline and Tobacco Craving in Smokers With Schizophrenia
NCT02968602 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Effects of Exercise in Smokers With Schizophrenia
NCT01635075 ·Status: COMPLETED ·Phase: PHASE2